135 related articles for article (PubMed ID: 10976583)
1. Pharmacological characterization of (10bS)-1,2,3,5,6,10b-hexahydropyrrolo[2,1-a]isoquinoline oxalate (YSL-3S) as a new alpha2-adrenoceptor antagonist.
Chung SH; Yook J; Min BJ; Lee JY; Lee YS; Jin C
Arch Pharm Res; 2000 Aug; 23(4):353-9. PubMed ID: 10976583
[TBL] [Abstract][Full Text] [Related]
2. The relationship between density of alpha-adrenoceptor binding sites and contractile responses in several porcine isolated blood vessels.
Wright IK; Blaylock NA; Kendall DA; Wilson VG
Br J Pharmacol; 1995 Feb; 114(3):678-88. PubMed ID: 7735695
[TBL] [Abstract][Full Text] [Related]
3. The pharmacology of RS-15385-197, a potent and selective alpha 2-adrenoceptor antagonist.
Brown CM; MacKinnon AC; Redfern WS; Hicks PE; Kilpatrick AT; Small C; Ramcharan M; Clague RU; Clark RD; MacFarlane CB
Br J Pharmacol; 1993 Feb; 108(2):516-25. PubMed ID: 8095420
[TBL] [Abstract][Full Text] [Related]
4. alpha(2)-adrenoceptor antagonist properties of OPC-28326, a novel selective peripheral vasodilator.
Orito K; Kishi M; Imaizumi T; Nakazawa T; Hashimoto A; Mori T; Kambe T
Br J Pharmacol; 2001 Oct; 134(4):763-70. PubMed ID: 11606316
[TBL] [Abstract][Full Text] [Related]
5. [3H]Rauwolscine: an antagonist radioligand for the cloned human 5-hydroxytryptamine2b (5-HT2B) receptor.
Wainscott DB; Sasso DA; Kursar JD; Baez M; Lucaites VL; Nelson DL
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan; 357(1):17-24. PubMed ID: 9459568
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of noradrenaline-induced contractions of the porcine isolated palmar lateral vein and palmar common digital artery.
Blaylock NA; Wilson VG
Br J Pharmacol; 1995 Feb; 114(3):694-702. PubMed ID: 7735696
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the alpha-adrenoceptor antagonist profiles of idazoxan (RX 781094), yohimbine, rauwolscine and corynanthine.
Doxey JC; Lane AC; Roach AG; Virdee NK
Naunyn Schmiedebergs Arch Pharmacol; 1984 Feb; 325(2):136-44. PubMed ID: 6144048
[TBL] [Abstract][Full Text] [Related]
8. [3H]-RS-15385-197, a selective and high affinity radioligand for alpha 2-adrenoceptors: implications for receptor classification.
MacKinnon AC; Kilpatrick AT; Kenny BA; Spedding M; Brown CM
Br J Pharmacol; 1992 Aug; 106(4):1011-8. PubMed ID: 1327384
[TBL] [Abstract][Full Text] [Related]
9. Characterization of binding sites for [3H]-idazoxan, [3H]-P-aminoclonidine and [3H]-rauwolscine in the kidney of the dog.
Evans RG; Haynes JM
Clin Exp Pharmacol Physiol; 1994 Aug; 21(8):649-58. PubMed ID: 7813124
[TBL] [Abstract][Full Text] [Related]
10. Identification of alpha 1-adrenoceptor subtypes in the rat vas deferens: binding and functional studies.
Ohmura T; Oshita M; Kigoshi S; Muramatsu I
Br J Pharmacol; 1992 Nov; 107(3):697-704. PubMed ID: 1361871
[TBL] [Abstract][Full Text] [Related]
11. Characterization of [3H]rauwolscine binding to alpha 2-adrenoceptor sites in the lumbar spinal cord of the cat: comparison to such binding sites in the cat frontal cerebral cortex.
Howe JR; Yaksh TL
Brain Res; 1986 Mar; 368(1):87-100. PubMed ID: 2869820
[TBL] [Abstract][Full Text] [Related]
12. Presynaptic imidazoline receptors and non-adrenoceptor [3H]-idazoxan binding sites in human cardiovascular tissues.
Molderings GJ; Likungu J; Jakschik J; Göthert M
Br J Pharmacol; 1997 Sep; 122(1):43-50. PubMed ID: 9298527
[TBL] [Abstract][Full Text] [Related]
13. Effects of imidazoline derivatives on cholinergic motility in guinea-pig ileum: involvement of presynaptic alpha2-adrenoceptors or imidazoline receptors?
Colucci R; Blandizzi C; Carignani D; Placanica G; Lazzeri G; Del Tacca M
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):682-91. PubMed ID: 9686946
[TBL] [Abstract][Full Text] [Related]
14. Species-selective binding of [3H]-idazoxan to alpha 2-adrenoceptors and non-adrenoceptor, imidazoline binding sites in the central nervous system.
Hussain JF; Kendall DA; Wilson VG
Br J Pharmacol; 1993 Jul; 109(3):831-7. PubMed ID: 8102937
[TBL] [Abstract][Full Text] [Related]
15. Unusual alpha-adrenoceptor subtype in canine saphenous vein: comparison to mesenteric vein.
Daniel EE; Low AM; Gaspar V; Lu-Chao H; Green J; Akrong J; Duerksen S; Soyka C; Chen CK; Boyd J; Kwan CY
Br J Pharmacol; 1996 Apr; 117(7):1535-43. PubMed ID: 8730751
[TBL] [Abstract][Full Text] [Related]
16. Evidence for a functional alpha 1A- (alpha 1C-) adrenoceptor mediating contraction of the rat epididymal vas deferens and an alpha 1B-adrenoceptor mediating contraction of the rat spleen.
Burt RP; Chapple CR; Marshall I
Br J Pharmacol; 1995 Jun; 115(3):467-75. PubMed ID: 7582458
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the subtypes of alpha2-adrenoceptor mediating prejunctional inhibition in rat atrium and cerebral cortex.
Ho SL; Honner V; Docherty JR
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):634-9. PubMed ID: 9686939
[TBL] [Abstract][Full Text] [Related]
18. Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain.
Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
Br J Pharmacol; 1990 Apr; 99(4):803-9. PubMed ID: 1972896
[TBL] [Abstract][Full Text] [Related]
19. Effects of dicentrine, a novel alpha 1-adrenoceptor antagonist, on human hyperplastic prostates.
Yu SM; Ko FN; Chueh SC; Chen J; Chen SC; Chen CC; Teng CM
Eur J Pharmacol; 1994 Jan; 252(1):29-34. PubMed ID: 7512043
[TBL] [Abstract][Full Text] [Related]
20. Characterization and autoradiographical localization of non-adrenoceptor idazoxan binding sites in the rat brain.
Mallard NJ; Hudson AL; Nutt DJ
Br J Pharmacol; 1992 Aug; 106(4):1019-27. PubMed ID: 1356565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
